EUCAST抗菌药物敏感性试验最新进展
欧洲抗菌药物敏感性试验委员会(EUCAST)是由欧洲临床微生物与感染病学会(ESCMID)组织、作为欧洲药品管理局(EMA)折点咨询委员会的国际药敏试验委员会。其工作从协调欧洲临床折点扩展至全球,包括汇总大量MIC分布、建立流行病学折点值(ECOFF)概念、开发EUCAST纸片扩散法,并设有真菌、分枝杆菌、兽医等常设分委员会。EUCAST近期修订了临床敏感性解释类别S、I、R的定义,承认药物暴露与敏感性报告之间的密切关系。
要点
- EUCAST是EMA的折点咨询委员会,其折点决定经公开咨询程序,新药保密期除外。
- EUCAST建立了ECOFF概念和纸片扩散法,并开发了展示MIC分布的软件。
- EUCAST近期修订S、I、R定义,强调药物暴露与敏感性报告的关系。
核心结论
- EUCAST已从协调欧洲临床折点扩展为具有全球影响力的药敏试验委员会,并持续修订解释类别定义。
研究设计与样本
- EUCAST是ESCMID组织的国际药敏试验委员会,并作为EMA的折点咨询委员会运作。
- EUCAST设有多个常设分委员会(AFST、AMST、VetCAST)和针对厌氧菌、MIC与抑菌圈直径分布、ECOFF、表型与基因型耐药关系、专家规则等主题的临时分委员会。
主要发现
- EUCAST的里程碑工作包括汇总大量MIC分布、创建展示这些分布的软件、建立ECOFF概念以及开发EUCAST纸片扩散法。
- EUCAST开发实验室在抗菌药物敏感性试验方法学开发中发挥关键作用,包括新抗菌药物开发工作和直接从血培养瓶进行快速AST。
- EUCAST近期修订了临床敏感性解释类别S、I、R的定义,承认药物暴露与敏感性报告之间的密切关系。
关键数值与推荐
- 所有EUCAST决定均需经过EUCAST公开咨询程序,唯一例外是新抗菌药物的折点,因许可过程中的保密协议无法公开参与。
临床怎么用
- 临床微生物实验室应关注EUCAST修订后的S、I、R定义,并在报告药敏结果时考虑药物暴露与敏感性解释的关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is an international susceptibility testing committee, organized by the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) and functioning as the breakpoint advisory committee of the European Medicines Agency (EMA). The original remit of EUCAST was to harmonize European clinical breakpoints, but very soon, the activities expanded beyond the borders of Europe and included newly licensed agents in Europe. Among the milestones were the aggregating of large numbers of MIC distributions, creating software to display these distributions, the EUCAST concept of identifying epidemiological cutoff values (ECOFF), and the development of a EUCAST disk diffusion method. The EUCAST Development Laboratory has played a critical role in the development of antimicrobial susceptibility testing (AST) methodology, including development work for novel antimicrobial agents and for rapid AST directly from blood culture bottles. EUCAST has several standing subcommittees, including for AST in fungi (AFST) and mycobacteria (AMST) and for microorganisms of veterinary interest (VetCAST), and ad hoc subcommittees on subjects such as anaerobic bacteria, MIC and zone diameter distributions and epidemiological cutoff values, the relationship between phenotypic and genotypic resistance, and expert rules and methods for the detection of resistance mechanisms. All EUCAST decisions are subjected to the EUCAST public consultation process, the only exception being breakpoints of novel antimicrobial agents where confidentiality agreements during the licensing process prevent public participation. EUCAST has recently revised the definitions of clinical susceptibility interpretive categories S, I, and R, acknowledging the intimate relationship between drug exposure and susceptibility reporting.
引用
- Giske CG, Turnidge J, Cantón R, et al. Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST). J Clin Microbiol. 2021. PMID: 34346716. doi:10.1128/JCM.00276-21
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。